You just read:

Germany's IQWiG Confirms That ThromboGenics' JETREA® Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole

News provided by

ThromboGenics NV

02 Aug, 2013, 06:30 BST